Comments
Loading...
Chemours Earnings Estimates, EPS & Revenue | NYSE:CC | Benzinga
Chemours reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 26
EPS Estimate
$0.440
Quarterly Revenue Estimate
$1.41B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$5.78B
Analyze the earnings history of Chemours using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CC | Chemours | $0.32 | $0.44 | — | — | $1.35B | $1.41B | — | — | 05/26/2025 | Get Alert |
| CC | Chemours | $0.31 | $0.16 | $0.11 | -31.25% | $1.37B | $1.37B | $1.36B | -0.80% | 02/18/2025 | Get Alert |
| CC | Chemours | $0.43 | $0.28 | $0.40 | 42.86% | $1.49B | $1.44B | $1.50B | 4.24% | 11/04/2024 | Get Alert |
| CC | Chemours | $1.10 | $0.57 | $0.38 | -33.33% | $1.64B | $1.53B | $1.54B | 0.52% | 08/01/2024 | Get Alert |
| CC | Chemours | $0.98 | $0.18 | $0.32 | 77.78% | $1.54B | $1.35B | $1.35B | 0.00% | 04/30/2024 | Get Alert |
| CC | Chemours | $0.00 | $0.25 | $0.31 | 24.00% | $1.34B | $1.32B | $1.36B | 3.11% | 03/27/2024 | Get Alert |
| CC | Chemours | $1.24 | $0.72 | $0.63 | -12.50% | $1.78B | $1.53B | $1.49B | -2.81% | 10/26/2023 | Get Alert |
| CC | Chemours | $1.89 | $1.07 | $1.10 | — | $1.92B | $1.69B | $1.64B | -2.96% | 07/27/2023 | Get Alert |
| CC | Chemours | $1.46 | $0.47 | $0.98 | 108.51% | $1.76B | $1.46B | $1.54B | 5.21% | 04/27/2023 | Get Alert |
| CC | Chemours | $0.81 | $0.08 | $0.00 | -100.00% | $1.57B | $1.27B | $1.34B | 5.35% | 02/09/2023 | Get Alert |
| CC | Chemours | $1.27 | $1.07 | $1.24 | 15.89% | $1.68B | $1.68B | $1.78B | 5.77% | 10/25/2022 | Get Alert |
| CC | Chemours | $1.20 | $1.42 | $1.89 | 33.10% | $1.66B | $1.84B | $1.92B | 4.08% | 07/28/2022 | Get Alert |
| CC | Chemours | $0.71 | $0.92 | $1.46 | 58.70% | $1.44B | $1.57B | $1.76B | 12.36% | 05/02/2022 | Get Alert |
| CC | Chemours | $0.61 | $0.92 | $0.81 | -11.96% | $1.34B | $1.57B | $1.57B | 0.32% | 02/10/2022 | Get Alert |
| CC | Chemours | $0.47 | $1.02 | $1.27 | 24.51% | $1.23B | $1.58B | $1.68B | 6.33% | 11/04/2021 | Get Alert |
| CC | Chemours | $0.18 | $0.92 | $1.20 | 30.43% | $1.09B | $1.52B | $1.66B | 8.88% | 07/29/2021 | Get Alert |
| CC | Chemours | $0.71 | $0.63 | $0.71 | 12.70% | $1.30B | $1.40B | $1.44B | 2.57% | 05/03/2021 | Get Alert |
| CC | Chemours | $0.56 | $0.41 | $0.61 | 48.78% | $1.35B | $1.28B | $1.34B | 4.45% | 02/11/2021 | Get Alert |
| CC | Chemours | $0.59 | $0.33 | $0.47 | 42.42% | $1.39B | $1.20B | $1.23B | 2.75% | 11/03/2020 | Get Alert |
| CC | Chemours | $0.72 | $0.10 | $0.18 | 80.00% | $1.41B | $1.09B | $1.09B | 0.28% | 07/30/2020 | Get Alert |
| CC | Chemours | $0.63 | $0.47 | $0.71 | 51.06% | $1.38B | $1.33B | $1.30B | -1.88% | 05/05/2020 | Get Alert |
Chemours (CC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-18 | $0.11 | $0.16 | -31.3 % |
| Q3 | 2024-11-04 | $0.40 | $0.28 | 42.9 % |
| Q2 | 2024-08-01 | $0.38 | $0.57 | -33.3 % |
| Q1 | 2024-04-30 | $0.32 | $0.18 | 77.8 % |
Chemours (CC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-18 | $1.36B | $1.37B | -0.80 % |
| Q3 | 2024-11-04 | $1.50B | $1.44B | 4.24 % |
| Q2 | 2024-08-01 | $1.54B | $1.53B | 0.52 % |
| Q1 | 2024-04-30 | $1.35B | $1.35B | 0.00 % |
FAQ
When is Chemours (NYSE:CC) reporting earnings?
Chemours (CC) is scheduled to report earnings on May 26, 2025. The last reported earnings were for reported on February 18, 2025 for Q4.
What were the latest earnings per share (EPS) for Chemours (NYSE:CC)?
The Actual EPS was $0.11, which missed the estimate of $0.16.
What were Chemours’s (NYSE:CC) revenues?
The Actual Revenue was $1.4B, which missed the estimate of $1.4B.
Browse earnings estimates, EPS, and revenue on all stocks.